Elif Güler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elif Güler has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Alphan Kupesiz
Division of Hematology, Department of Paediatrics, Faculty of Medicine, Akdeniz University, 07070 Antalya, Turkey
4 shared publications - Funda Tayfun Küpesiz
Division of Pediatric Hematology and Oncology Akdeniz University Faculty of Medicine Antalya Türkiye
4 shared publications Alphan Küpesiz
2 shared publications- Ayşe Nur Akınel2 shared publications
- Ayşe Çiğdem Sivrice
Clinic of Pediatric Hematology and Oncology, Isparta City Hospital, Isparta, Türkiye
2 shared publications - Gülen Tüysüz
Akdeniz University Hospital, Department of Children's Health and Diseases, Antalya, Turkey
2 shared publications
Latest Publications
- Open Access
Sleep Patterns Across the Transfusion Cycle in Children with Transfusion-Dependent β-Thalassemia: A 14-Day Prospective Controlled Study Using Sleep Diaries and Repeated Questionnaires
Background/Objectives: Sleep across the transfusion cycle remains understudied in children with transfusion-dependent β-thalassemia (TDT). We assessed sleep patterns and hematologic correlates before and after transfusion. Methods: This prospective, controlled, repeated-measures study included 27 children with TDT and 30 controls who had been frequency-matched at recruitment on age, sex, and school-attendance category; no fixed one-to-one patient–control pairs were formed. Participants completed 14-day sleep diaries spanning the pre- and post-transfusion weeks and repeated Children’s Sleep Habits Questionnaire (CSHQ) and Pittsburgh Sleep Quality Index (PSQI) assessments. The three primary outcome domains were sleep-diary measures (including sleep regularity, daytime nap frequency, sleep-duration variability, and nocturnal awakenings), continuous CSHQ total and subscale scores, and the continuous modified PSQI global score. Threshold classifications, individual questionnaire items, and laboratory/MRI associations were exploratory. Multiplicity was controlled within the diary and questionnaire families using the Benjamini–Hochberg false discovery rate (FDR). Results: Within the primary sleep-diary domain, weekday sleep irregularity was greater in patients pre-transfusion (16.3 vs. 10.2 min; q = 0.014) but not post-transfusion (q = 0.220); sleep-duration variability was greater before and after transfusion (both q = 0.026), and diaries recorded more daytime naps and more and longer nocturnal awakenings across 14 days (q < 0.05). Within the primary questionnaire domains, the continuous modified PSQI global score and CSHQ total, sleep-behavior, and daytime-sleepiness scores were higher in patients pre-transfusion (all q < 0.001). In exploratory, unadjusted analyses, lower pre-transfusion hemoglobin correlated with greater daytime sleepiness (ρ = −0.425; p = 0.027). Conclusions: Multiplicity-adjusted findings across the three primary outcome domains suggest differences in reported sleep timing, regularity, continuity, daytime napping, and questionnaire scores in children with TDT. However, the small sample, the number of component outcomes and contrasts, and the absence of actigraphy require cautious interpretation.
Open AccessSleep Patterns Across the Transfusion Cycle in Children with Transfusion-Dependent β-Thalassemia: A 14-Day Prospective Controlled Study Using Sleep Diaries and Repeated Questionnaires
Background/Objectives: Sleep across the transfusion cycle remains understudied in children with transfusion-dependent β-thalassemia (TDT). We assessed sleep patterns and hematologic correlates before and after transfusion. Methods: This prospective, controlled, repeated-measures study included 27 children with TDT and 30 controls who had been frequency-matched at recruitment on age, sex, and school-attendance category; no fixed one-to-one patient–control pairs were formed. Participants completed 14-day sleep diaries spanning the pre- and post-transfusion weeks and repeated Children’s Sleep Habits Questionnaire (CSHQ) and Pittsburgh Sleep Quality Index (PSQI) assessments. The three primary outcome domains were sleep-diary measures (including sleep regularity, daytime nap frequency, sleep-duration variability, and nocturnal awakenings), continuous CSHQ total and subscale scores, and the continuous modified PSQI global score. Threshold classifications, individual questionnaire items, and laboratory/MRI associations were exploratory. Multiplicity was controlled within the diary and questionnaire families using the Benjamini–Hochberg false discovery rate (FDR). Results: Within the primary sleep-diary domain, weekday sleep irregularity was greater in patients pre-transfusion (16.3 vs. 10.2 min; q = 0.014) but not post-transfusion (q = 0.220); sleep-duration variability was greater before and after transfusion (both q = 0.026), and diaries recorded more daytime naps and more and longer nocturnal awakenings across 14 days (q < 0.05). Within the primary questionnaire domains, the continuous modified PSQI global score and CSHQ total, sleep-behavior, and daytime-sleepiness scores were higher in patients pre-transfusion (all q < 0.001). In exploratory, unadjusted analyses, lower pre-transfusion hemoglobin correlated with greater daytime sleepiness (ρ = −0.425; p = 0.027). Conclusions: Multiplicity-adjusted findings across the three primary outcome domains suggest differences in reported sleep timing, regularity, continuity, daytime napping, and questionnaire scores in children with TDT. However, the small sample, the number of component outcomes and contrasts, and the absence of actigraphy require cautious interpretation.
- 17 February 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 48 (2) , e78-e83
Evaluation of Post-Traumatic Stress Disorder and Perception of Loneliness in Children Who Underwent Hematopoietic Stem Cell Transplantation
Background: Hematopoietic stem cell transplantation (HSCT) is associated with post-traumatic stress disorder (PTSD), depression, and anxiety in pediatric survivors, but studies on loneliness in these patients remain limited. Aim: This study aims to explore how PTSD relates to perceptions of loneliness, depression, and anxiety disorders among pediatric HSCT survivors. Methods: This cross-sectional study included 60 patients who underwent HSCT, 60 patients with various hematological/oncological conditions who did not undergo HSCT, and 65 controls. The Child Post-Traumatic Stress Reaction Index, the UCLA Loneliness Scale, and the Revised Children’s Anxiety and Depression Scale were used to assess PTSD, perceptions of loneliness, and depression and anxiety disorders, respectively. Results: Both HSCT (+) and HSCT (−) groups demonstrated significantly higher PTSD, depression, and anxiety scores compared with the control group. Perceived loneliness was significantly higher in the HSCT (+) group compared with the HSCT (−) and control groups. In addition, a significant positive correlation was observed between PTSD scores and loneliness scores in HSCT (+) and HSCT (−) groups. Conclusion: Staying in an isolation room during HSCT may be a contributing factor to loneliness and PTSD in pediatric survivors. Early recognition and treatment of PTSD symptoms and addressing loneliness are crucial for effective care during and after HSCT.
- 17 February 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 48 (2) , e78-e83
Evaluation of Post-Traumatic Stress Disorder and Perception of Loneliness in Children Who Underwent Hematopoietic Stem Cell Transplantation
Background: Hematopoietic stem cell transplantation (HSCT) is associated with post-traumatic stress disorder (PTSD), depression, and anxiety in pediatric survivors, but studies on loneliness in these patients remain limited. Aim: This study aims to explore how PTSD relates to perceptions of loneliness, depression, and anxiety disorders among pediatric HSCT survivors. Methods: This cross-sectional study included 60 patients who underwent HSCT, 60 patients with various hematological/oncological conditions who did not undergo HSCT, and 65 controls. The Child Post-Traumatic Stress Reaction Index, the UCLA Loneliness Scale, and the Revised Children’s Anxiety and Depression Scale were used to assess PTSD, perceptions of loneliness, and depression and anxiety disorders, respectively. Results: Both HSCT (+) and HSCT (−) groups demonstrated significantly higher PTSD, depression, and anxiety scores compared with the control group. Perceived loneliness was significantly higher in the HSCT (+) group compared with the HSCT (−) and control groups. In addition, a significant positive correlation was observed between PTSD scores and loneliness scores in HSCT (+) and HSCT (−) groups. Conclusion: Staying in an isolation room during HSCT may be a contributing factor to loneliness and PTSD in pediatric survivors. Early recognition and treatment of PTSD symptoms and addressing loneliness are crucial for effective care during and after HSCT.
- Open Access
- 23 October 2023
- Published by Akdeniz University in Akdeniz Medical Journal
Hemoglobin D and Coinheritance with Hb S, β-thalassemia
Objective: Hb D-Punjab (also known as D-Los Angeles) is a recessively inherited variant of hemoglobin. It is one of the most common hemoglobin variants worldwide. In this study, we aimed to evaluate the hematological features of our homozygous and heterozygous Hb D patients and patients with compound heterozygosity for Hb D and other hemoglobinopathies in terms of clinical and laboratory findings. Methods: In this study, cases with Hb D-Punjab have been identified in both the heterozygous and homozygous states, as well as coinheritance with Hb S or β-thalassemia. We presented the clinical and laboratory characteristics of 18 cases (Hb D/D (n=2), Hb D/β-thalassemia (n=3), and Hb S/D (n=3) and Hb D traits (n=10)). Results: As a result of the study, it was observed that Hb D was asymptomatic in both heterozygous and homozygous forms. Hb D/β thalassemia cases showed mild microcytic and hypochromic anemia, but they were clinically normal. Compound heterozygosity for Hb S/D showed moderate hemolytic anemia, but a severe clinical picture with painful crises, just like sickle cell patients. Conclusion: Hemoglobin D-Punjab, which is asymptomatic even in homozygous conditions, can cause a variety of clinical pictures from mild to severe when inherited in combination with other hemoglobinopathies.
- 23 October 2023
- Published by Akdeniz University in Akdeniz Medical Journal
Open AccessHemoglobin D and Coinheritance with Hb S, β-thalassemia
Objective: Hb D-Punjab (also known as D-Los Angeles) is a recessively inherited variant of hemoglobin. It is one of the most common hemoglobin variants worldwide. In this study, we aimed to evaluate the hematological features of our homozygous and heterozygous Hb D patients and patients with compound heterozygosity for Hb D and other hemoglobinopathies in terms of clinical and laboratory findings. Methods: In this study, cases with Hb D-Punjab have been identified in both the heterozygous and homozygous states, as well as coinheritance with Hb S or β-thalassemia. We presented the clinical and laboratory characteristics of 18 cases (Hb D/D (n=2), Hb D/β-thalassemia (n=3), and Hb S/D (n=3) and Hb D traits (n=10)). Results: As a result of the study, it was observed that Hb D was asymptomatic in both heterozygous and homozygous forms. Hb D/β thalassemia cases showed mild microcytic and hypochromic anemia, but they were clinically normal. Compound heterozygosity for Hb S/D showed moderate hemolytic anemia, but a severe clinical picture with painful crises, just like sickle cell patients. Conclusion: Hemoglobin D-Punjab, which is asymptomatic even in homozygous conditions, can cause a variety of clinical pictures from mild to severe when inherited in combination with other hemoglobinopathies.
- Open Access
- 15 December 2022
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 33 (12) , 1069-1078
Multidisciplinary Management of Pediatric Hepatoblastoma: A 20-Year Single-Center Experience
Background: Hepatoblastoma is rare cancer that responds well to risk-based chemotherapy, and surgical treatment is needed to achieve complete remission and satisfactory survival rates in hepatoblastoma patients. In this study, we evaluated the clinical features and treatment outcomes of pediatric hepatoblastoma patients treated in our clinic. Methods: Eighteen patients with hepatoblastoma who were treated and followed up in our center between June 1999 and June 2020 were analyzed retrospectively. All patients were evaluated by a multidisciplinary team and managed using a risk-based protocol (SIOPEL-1 and SIOPEL-3). Results: The patients’ mean age at diagnosis was 38.33 ± 52.34 months. Sixteen patients (89%) received neoadjuvant chemotherapy, and 2 patients (11%) who underwent complete mass excision at diagnosis received adjuvant chemotherapy. After neoadjuvant therapy, the tumor was completely resected in 8 patients (45%), while liver transplantation was performed in 6 patients (34%) because complete resection of the tumor was not possible. Two patients died before surgical treatment. One patient relapsed with lung metastasis after salvage chemotherapy. She is alive without disease at 64 months. The mean follow-up time was 59.3 ± 49.8 months; 5-year overall and disease-free survival rates were 88.9% and 80.8%, respectively. The 5-year overall survival rate was 100% for both liver transplant and resected patients, whereas 5-year disease-free survival was lower in transplant patients (75% vs 100%, P < .001). Conclusion: Multidisciplinary follow-up is especially important for patients who may need liver transplantation. Some patients may benefit from new treatment options such as radiofrequency ablation and cyberknife treatment. Cite this article as: Tayfun Küpesiz F, Akınel AN, Akbaş H, et al. Multidisciplinary management of pediatric hepatoblastoma: A 20-year single-center experience. Turk J Gastroenterol. 2022;33(12):1069-1078.
- 15 December 2022
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 33 (12) , 1069-1078
Open AccessMultidisciplinary Management of Pediatric Hepatoblastoma: A 20-Year Single-Center Experience
Background: Hepatoblastoma is rare cancer that responds well to risk-based chemotherapy, and surgical treatment is needed to achieve complete remission and satisfactory survival rates in hepatoblastoma patients. In this study, we evaluated the clinical features and treatment outcomes of pediatric hepatoblastoma patients treated in our clinic. Methods: Eighteen patients with hepatoblastoma who were treated and followed up in our center between June 1999 and June 2020 were analyzed retrospectively. All patients were evaluated by a multidisciplinary team and managed using a risk-based protocol (SIOPEL-1 and SIOPEL-3). Results: The patients’ mean age at diagnosis was 38.33 ± 52.34 months. Sixteen patients (89%) received neoadjuvant chemotherapy, and 2 patients (11%) who underwent complete mass excision at diagnosis received adjuvant chemotherapy. After neoadjuvant therapy, the tumor was completely resected in 8 patients (45%), while liver transplantation was performed in 6 patients (34%) because complete resection of the tumor was not possible. Two patients died before surgical treatment. One patient relapsed with lung metastasis after salvage chemotherapy. She is alive without disease at 64 months. The mean follow-up time was 59.3 ± 49.8 months; 5-year overall and disease-free survival rates were 88.9% and 80.8%, respectively. The 5-year overall survival rate was 100% for both liver transplant and resected patients, whereas 5-year disease-free survival was lower in transplant patients (75% vs 100%, P < .001). Conclusion: Multidisciplinary follow-up is especially important for patients who may need liver transplantation. Some patients may benefit from new treatment options such as radiofrequency ablation and cyberknife treatment. Cite this article as: Tayfun Küpesiz F, Akınel AN, Akbaş H, et al. Multidisciplinary management of pediatric hepatoblastoma: A 20-year single-center experience. Turk J Gastroenterol. 2022;33(12):1069-1078.
- 7 September 2022
- Published by Hindawi Limited in European Journal of Cancer Care
- Vol. 31 (6) , e13698
The effect of a peer‐assisted video‐based training programme and counselling to reduce anxiety in children newly diagnosed with cancer: Non‐randomised controlled trial
Objective The aim of this study is to evaluate the effect of 'peer-assisted video-based education programme' (VTPA) and counselling to reduce anxiety in children newly diagnosed with cancer. Methods A non-randomised controlled trial design with repeated measures was conducted. The sample of the study consisted of 50 children between the ages of 9 and 18 who were newly diagnosed with cancer in the hospital. Intervention and control groups were created. Children in the intervention group received both VTPA training and counselling practice 3 days a week for 2 months. Data were collected with the State-Trait Anxiety Inventory for Children. The basal assessment in the research was the first meeting with the child, with interval assessments 1 month after, 2 months after and 3 months after the education. Results In the study, it was determined that the state anxiety mean scores of the children in the PAVEP and control groups differed over time (p < 0.05). However, it was determined that there was no difference between the trait anxiety mean scores of the children (p > 0.05). Conclusion VTPA with peer assistance and counselling application supported the reduction of state anxiety in children newly diagnosed with cancer over time.
- 7 September 2022
- Published by Hindawi Limited in European Journal of Cancer Care
- Vol. 31 (6) , e13698
The effect of a peer‐assisted video‐based training programme and counselling to reduce anxiety in children newly diagnosed with cancer: Non‐randomised controlled trial
Objective The aim of this study is to evaluate the effect of 'peer-assisted video-based education programme' (VTPA) and counselling to reduce anxiety in children newly diagnosed with cancer. Methods A non-randomised controlled trial design with repeated measures was conducted. The sample of the study consisted of 50 children between the ages of 9 and 18 who were newly diagnosed with cancer in the hospital. Intervention and control groups were created. Children in the intervention group received both VTPA training and counselling practice 3 days a week for 2 months. Data were collected with the State-Trait Anxiety Inventory for Children. The basal assessment in the research was the first meeting with the child, with interval assessments 1 month after, 2 months after and 3 months after the education. Results In the study, it was determined that the state anxiety mean scores of the children in the PAVEP and control groups differed over time (p < 0.05). However, it was determined that there was no difference between the trait anxiety mean scores of the children (p > 0.05). Conclusion VTPA with peer assistance and counselling application supported the reduction of state anxiety in children newly diagnosed with cancer over time.
- 25 October 2021
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 63 (5) , 884-892
Can peripheral blood monocyte percentage and lymphocyte monocyte ratio at diagnosis predict survival in pediatric neuroblastoma patients?
Background. Previous studies have shown that the immune system plays a critical role in cancer pathogenesis. The lymphocyte monocyte ratio (LMR) and monocyte percentage (MP) have been found to be prognostic factors in various types of adult cancers. But studies about pediatric tumors are scarce and to our knowledge, there are no studies evaluating the immune system effect in pediatric neuroblastoma patients. The aim of this study was to assess whether LMR and MP at diagnosis may have an effect on prognosis in neuroblastoma patients. Methods. We retrospectively analyzed MP and LMR at diagnosis in 71 pediatric neuroblastoma patients treated between 2002 and 2016. Results. The optimal cut-off values of LMR and MP were determined using the receiver operating characteristics curves (ROC) and area under the curve (AUC). We found that a low LMR (≤3.5) and a high MP (≥7.5%) were correlated with worse overall survival and shorter event-free survival in univariate analysis. Multivariate analysis revealed that elevated LMR was an independent factor for better OS and EFS. Conclusions. In conclusion, LMR and MP might be valuable prognostic factors for predicting OS in neuroblastoma patients. Multicenter and prospective studies are warranted to confirm this hypothesis.
- 25 October 2021
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 63 (5) , 884-892
Can peripheral blood monocyte percentage and lymphocyte monocyte ratio at diagnosis predict survival in pediatric neuroblastoma patients?
Background. Previous studies have shown that the immune system plays a critical role in cancer pathogenesis. The lymphocyte monocyte ratio (LMR) and monocyte percentage (MP) have been found to be prognostic factors in various types of adult cancers. But studies about pediatric tumors are scarce and to our knowledge, there are no studies evaluating the immune system effect in pediatric neuroblastoma patients. The aim of this study was to assess whether LMR and MP at diagnosis may have an effect on prognosis in neuroblastoma patients. Methods. We retrospectively analyzed MP and LMR at diagnosis in 71 pediatric neuroblastoma patients treated between 2002 and 2016. Results. The optimal cut-off values of LMR and MP were determined using the receiver operating characteristics curves (ROC) and area under the curve (AUC). We found that a low LMR (≤3.5) and a high MP (≥7.5%) were correlated with worse overall survival and shorter event-free survival in univariate analysis. Multivariate analysis revealed that elevated LMR was an independent factor for better OS and EFS. Conclusions. In conclusion, LMR and MP might be valuable prognostic factors for predicting OS in neuroblastoma patients. Multicenter and prospective studies are warranted to confirm this hypothesis.
- Open Access
- 25 August 2021
- Published by Galenos Yayinevi in Güncel Pediatri
- Vol. 19 (2) , 176-184
Clinical Characteristics and Treatment Outcomes of Patients with Malignant Extracranial Germ Cell Tumors: A 20-Year Single-Center Experience
- 25 August 2021
- Published by Galenos Yayinevi in Güncel Pediatri
- Vol. 19 (2) , 176-184
Open AccessClinical Characteristics and Treatment Outcomes of Patients with Malignant Extracranial Germ Cell Tumors: A 20-Year Single-Center Experience
- Open Access
- 17 December 2020
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 50 (8) , 1916-1921
Cross-sectional study: long term follow-up care for pediatric cancer survivors in a developing country, Turkey: current status, challenges, and future perspectives
The main purpose of this study is to determine; the current status of long term follow up (LTFU) for childhood cancer survivors and the challenges of LTFU for pediatric cancer survivors at pediatric oncology institutions in Turkey. An e-mailed questionnaire has been sent to directors of 33 pediatric oncology centers registered in the Turkish Pediatric Oncology Group (TPOG).Twenty one of 33 active institutions of the TPOG participated in the study and returned their completed questionnaires. Only 1 of the 21 participating centers had a separate LTFU clinic. The remaining centers had provided LTFU care for chilhood cancer survivors at the pediatric oncology outpatient clinic. Seventeen (80.9%) centers reported difficulty transition from pediatric clinic to adult clinic, 14 centers (66.6%) reported insufficient care providers, 12 (57.1%) centers reported insufficient time and transportation problems. As neglected late effects; 16 (76.1%) centers reported psychosocial and getty job problems, 11 (52.3%) centers reported sexual and cognitive problems. None of the centers have their own LTFU guideline for their daily LTFU practice. This study is the first to gain an overview of the needs of pediatric oncology centers and the gaps in survivorship services in Turkey. The results from this study will help develope a national health care system and national guideline for pediatric cancer survivors.
- 17 December 2020
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 50 (8) , 1916-1921
Open AccessCross-sectional study: long term follow-up care for pediatric cancer survivors in a developing country, Turkey: current status, challenges, and future perspectives
The main purpose of this study is to determine; the current status of long term follow up (LTFU) for childhood cancer survivors and the challenges of LTFU for pediatric cancer survivors at pediatric oncology institutions in Turkey. An e-mailed questionnaire has been sent to directors of 33 pediatric oncology centers registered in the Turkish Pediatric Oncology Group (TPOG).Twenty one of 33 active institutions of the TPOG participated in the study and returned their completed questionnaires. Only 1 of the 21 participating centers had a separate LTFU clinic. The remaining centers had provided LTFU care for chilhood cancer survivors at the pediatric oncology outpatient clinic. Seventeen (80.9%) centers reported difficulty transition from pediatric clinic to adult clinic, 14 centers (66.6%) reported insufficient care providers, 12 (57.1%) centers reported insufficient time and transportation problems. As neglected late effects; 16 (76.1%) centers reported psychosocial and getty job problems, 11 (52.3%) centers reported sexual and cognitive problems. None of the centers have their own LTFU guideline for their daily LTFU practice. This study is the first to gain an overview of the needs of pediatric oncology centers and the gaps in survivorship services in Turkey. The results from this study will help develope a national health care system and national guideline for pediatric cancer survivors.
- Open Access
- 1 January 2019
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 36 (1) , 82-86
Pediatric tonsillar synovial sarcoma- very rare localization: a case report and review of the literature
Tonsillar synovial sarcoma is an extremely rare entity and only 9 adult patients have been reported up to now. Here, we describe the first pediatric tonsillar synovial sarcoma of the literature in a patient who presented with a 2-month history of dysphagia and snoring. Clinical and radiological examinations showed that the tumor arose from the right palatine tonsil and narrowed the parapharyngeal space. An incisional biopsy from the palatine tonsil revealed the diagnosis of synovial sarcoma. The patient has underwent total tonsillectomy and received radiotherapy and chemotherapy because of the positive surgical margins. The patient is clinically in good condition and free of tumor 30 months after the initial diagnosis. We achieved a long-term complete remission with a combination of surgery, radiotherapy and chemotherapy in our case. Tonsillar synovial sarcoma should be kept in mind while dealing with tonsillar masses. We can conclude that a multidisciplinary approach is warranted while treating synovial sarcoma with this localization.
- 1 January 2019
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 36 (1) , 82-86
Open AccessPediatric tonsillar synovial sarcoma- very rare localization: a case report and review of the literature
Tonsillar synovial sarcoma is an extremely rare entity and only 9 adult patients have been reported up to now. Here, we describe the first pediatric tonsillar synovial sarcoma of the literature in a patient who presented with a 2-month history of dysphagia and snoring. Clinical and radiological examinations showed that the tumor arose from the right palatine tonsil and narrowed the parapharyngeal space. An incisional biopsy from the palatine tonsil revealed the diagnosis of synovial sarcoma. The patient has underwent total tonsillectomy and received radiotherapy and chemotherapy because of the positive surgical margins. The patient is clinically in good condition and free of tumor 30 months after the initial diagnosis. We achieved a long-term complete remission with a combination of surgery, radiotherapy and chemotherapy in our case. Tonsillar synovial sarcoma should be kept in mind while dealing with tonsillar masses. We can conclude that a multidisciplinary approach is warranted while treating synovial sarcoma with this localization.